Treatment of Postoperative Crohn’s Disease
Authors:
- Florian FroehlichFFFlorian Froehlich
- Pascal JuilleratPJPascal Juillerat
- Christian FelleyCFChristian Felley
- Christian MottetCMChristian Mottet
- John-Paul VaderJVJohn-Paul Vader
- Bernard BurnandBBBernard Burnand
- Pierre MichettiPMPierre Michetti
- Jean-Jacques GonversJGJean-Jacques Gonvers
- 1 March 2005
- journal article
- review article
- Published by S. Karger AG in Digestion
- Vol. 71 (1) , 49-53
Abstract
At 1 year after a first resection, up to 80% of patients show an endoscopic recurrence, 10–20% have clinical relapse, and 5% have surgical recurrence. Smoking is one of the most important risk factors for postoperative recurrence. Preoperative disease activity and the severity of endoscopic lesions in the neoterminal ileum within the first postoperative year are predictors of symptomatic recurrence. Mesalamine is generally the first-line treatment used in the postoperative setting but still provokes considerable controversy as to its efficacy, in spite of the results of a meta-analysis. Immunosuppressive treatment (azathioprine, 6-MP) is based on scant evidence but is currently used as a second-line treatment in postsurgical patients at high risk for recurrence, with symptoms or with early endoscopic lesions in the neoterminal ileum. Nitroimidazole antibiotics (metronidazole, ornidazole) are also effective in the control of active Crohn’s disease in the postoperative setting. Given their known toxicity, they may be used as a third-line treatment as initial short-term prevention therapy rather than for long-term use. Conventional corticosteroids, budesonide or probiotics have no proven role in postoperative prophylaxis. Infliximab has not as yet been studied for use in the prevention of relapse after surgery.Keywords
This publication has 39 references indexed in Scilit:
- Inflammatory bowel diseaseGastroenterology Clinics of North America, 2002
- Low-dose budesonide treatment for prevention of postoperative recurrence of Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1999
- Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trialGastroenterology, 1998
- Preventing postoperative recurrence of Crohn's diseaseBritish Journal of Surgery, 1997
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupGastroenterology, 1997
- Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Surgical recurrence of perforating and nonperforating Crohn's diseaseDiseases of the Colon & Rectum, 1996
- Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease.Gut, 1995
- Factors influencing postoperative recurrence of Crohn's disease in childhood.Gut, 1991
- The results of ileorectal anastomosis at St Mark's Hospital from 1953 to 1968Gut, 1970